James Cheng‐Chung Wei
China Medical University(TW)Chung Shan Medical University Hospital(TW)Chung Shan Medical University(TW)
Publications by Year
Research Areas
Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Psoriasis: Treatment and Pathogenesis, Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection(2009)3,561 cited
- → The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general(2010)1,704 cited
- → Lie Algebraic Solution of Linear Differential Equations(1963)644 cited
- → Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine Kinase(2003)518 cited
- → Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial(2017)482 cited